Results 71 to 80 of about 9,325 (168)

Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Ovarian cancer (OC) remains a lethal gynecological malignancy with challenges in early diagnosis, treatment monitoring, and overcoming drug resistance. Liquid biopsy, a noninvasive approach analyzing tumor‐derived components in bodily fluids, has emerged as a promising tool in OC management.
Jingxia Zhang, Weiyan Shan, Jie Yu, Huan Shi, Qiaoping Xu, Hongkai Shang   +5 more
wiley   +1 more source

Effects of Prehabilitation by Physical Activity on Fatigue After Surgery for Colorectal Cancer. Results From Secondary Analyses in the Randomized Controlled Trial PHYSSURG‐C

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Objective The objective of this study is to explore effects on self‐reported fatigue at 4 weeks and 12 months after surgery in patients with colorectal cancer undergoing a pre‐ and postoperative exercise intervention compared to standard care in a randomized trial.
Kevin Afshari, Aron Onerup, Ying Li, Eva Angenete, Carolina Ehrencrona, Anette Wedin, Eva Haglind   +6 more
wiley   +1 more source

Quality of life in peritoneal carcinomatosis: A prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) [PDF]

, 2014
BACKGROUND/AIMS Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (HIPEC) can improve survival in selected patients with peritoneal carcinomatosis, but bear a significant risk of perioperative morbidity.
Niess, Hanno, Werner, Jens, Graeb, Christian, Angele, Martin K., Hauer, Alexandra, Albertsmeier, Markus   +5 more
core   +1 more source

Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO2 recirculation (HIPEC-CO2) for colorectal cancer peritoneal metastases: analysis of short-term outcomes

, 2021
Peritoneal dissemination from colorectal cancer (CRC) has long been associated with unfavorable prognosis. However, in the last decades, the combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) was able to ...
Abatini C., Di Giorgio A., Attalla El Halabieh M., Santullo F., Pacelli F., Lodoli C., Rotolo S., Andrea Di Giorgio, Claudio Lodoli, Miriam Attalla El Halabieh, Francesco Santullo, Stefano Rotolo, Carlo Abatini, Fabio Pacelli   +13 more
core   +1 more source

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies

, 2022
Objective Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) represent a mainstay of treatment for peritoneal malignancies.
Claramae Shulyn Chia, Johnny Ong, Jolene Si Min Wong, Khee Chee Soo, Louis Choon Kit Wong, Chin-Ann Johnny Ong, Claramae Chia, Chin Jin Seo   +7 more
core   +1 more source

HIPEC in advanced epithelial ovarian cancer: why is there controversy?

, 2020
: Purpose of review The randomized OVHIPEC study provided further evidence that adding heated intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery significantly improved recurrence-free and overall survival in stage III epithelial ...
Brand, Alison, Jan B. Vermorken, Peter van Dam, Alison Brand, Van Dam, Peter, Vermorken, Jan B.   +5 more
core   +1 more source

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

BMC Cancer, 2019
Background To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study.
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao, Min Yan, Zheng-Gang Zhu   +5 more
doaj   +1 more source

Is there a role for HIPEC in ovarian cancer?

, 2018
Hyperthermic intraperitoneal chemotherapy (HIPEC) is promoted by some as a standard treatment for peritoneal carcinomatosis of epithelial ovarian cancer (EOC) and other tumor entities, despite lack of robust data supporting this.
Harter, Philipp, Chiva, Luis, Sehouli, Jalid, Vergote, Ignace, Mahner, Sven, Fotopoulou, Christina, du Bois, Andreas, Gonzalez-Martin, Antonio   +7 more
core   +1 more source

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC: vloga anesteziologa [PDF]

, 2010
The diagnosis of peritoneal carcinomatosis is often associated with poor prognosis and a median survival of a few months, depending on the primary tumor.
Novak, Barbka
core   +1 more source

Exploring flow rate selection in HIPEC procedures

, 2016
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a main comprehensive treatment of peritoneal malignancies.
CRISTIANO SOUZA LEÃO, THALES PAULO BATISTA, LEVON BADIGLIAN FILHO   +2 more
core   +2 more sources